Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

November 01, 1995; Volume 48,Issue 5
  • You have access
    Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction.
    A Jagerschmidt, N Guillaume, N Goudreau, B Maigret and B P Roques
    Molecular Pharmacology November 1995, 48 (5) 783-789;
  • You have access
    Growth hormone regulation of male-specific rat liver P450s 2A2 and 3A2: induction by intermittent growth hormone pulses in male but not female rats rendered growth hormone deficient by neonatal monosodium glutamate.
    D J Waxman, P A Ram, N A Pampori and B H Shapiro
    Molecular Pharmacology November 1995, 48 (5) 790-797;
  • You have access
    Hypophosphorylation of topoisomerase II in etoposide (VP-16)-resistant human leukemia K562 cells associated with reduced levels of beta II protein kinase C.
    M K Ritke, N R Murray, W P Allan, A P Fields and J C Yalowich
    Molecular Pharmacology November 1995, 48 (5) 798-805;
  • You have access
    Species differences in A1 adenosine receptor/G protein coupling: identification of a membrane protein that stabilizes the association of the receptor/G protein complex.
    C Nanoff, T Mitterauer, F Roka, M Hohenegger and M Freissmuth
    Molecular Pharmacology November 1995, 48 (5) 806-817;
  • You have access
    Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor.
    F Ozcelebi, M H Holtmann, R U Rentsch, R Rao and L J Miller
    Molecular Pharmacology November 1995, 48 (5) 818-824;
  • You have access
    Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes.
    C García-Ruiz, A Colell, A Morales, N Kaplowitz and J C Fernández-Checa
    Molecular Pharmacology November 1995, 48 (5) 825-834;
  • You have access
    Subunit composition determines picrotoxin and bicuculline sensitivity of Drosophila gamma-aminobutyric acid receptors.
    H G Zhang, H J Lee, T Rocheleau, R H ffrench-Constant and M B Jackson
    Molecular Pharmacology November 1995, 48 (5) 835-840;
  • You have access
    Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
    T Priestley, P Laughton, J Myers, B Le Bourdellés, J Kerby and P J Whiting
    Molecular Pharmacology November 1995, 48 (5) 841-848;
  • You have access
    Differential coupling of glucagon and beta-adrenergic receptors with the small and large forms of the stimulatory G protein.
    T Yagami
    Molecular Pharmacology November 1995, 48 (5) 849-854;
  • You have access
    Glutamine transaminase K is not a major cysteine S-conjugate beta-lyase of rat kidney mitochondria: evidence that a high-molecular weight enzyme fulfills this role.
    D G Abraham, R J Thomas and A J Cooper
    Molecular Pharmacology November 1995, 48 (5) 855-860;
  • You have access
    Chronic ethanol consumption differentially alters the expression of gamma-aminobutyric acidA receptor subunit mRNAs in rat cerebral cortex: competitive, quantitative reverse transcriptase-polymerase chain reaction analysis.
    L L Devaud, F D Smith, D R Grayson and A L Morrow
    Molecular Pharmacology November 1995, 48 (5) 861-868;
  • You have access
    Molecular cloning and expression of multiple isoforms of human prostaglandin E receptor EP3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions.
    M Kotani, I Tanaka, Y Ogawa, T Usui, K Mori, A Ichikawa, S Narumiya, T Yoshimi and K Nakao
    Molecular Pharmacology November 1995, 48 (5) 869-879;
  • You have access
    Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments.
    J Chen, H E Nye, M B Kelz, N Hiroi, Y Nakabeppu, B T Hope and E J Nestler
    Molecular Pharmacology November 1995, 48 (5) 880-889;
  • You have access
    Activation of thromboxane and prostacyclin receptors elicits opposing effects on vascular smooth muscle cell growth and mitogen-activated protein kinase signaling cascades.
    D A Jones, C W Benjamin and D A Linseman
    Molecular Pharmacology November 1995, 48 (5) 890-896;
  • You have access
    In vitro transcription of DNA containing 2-chloro-2'-deoxyadenosine monophosphate.
    P Hentosh and M Tibudan
    Molecular Pharmacology November 1995, 48 (5) 897-904;
  • You have access
    Inhibition of splicing of wild-type and mutated luciferase-adenovirus pre-mRNAs by antisense oligonucleotides.
    D Hodges and S T Crooke
    Molecular Pharmacology November 1995, 48 (5) 905-918;
  • You have access
    Pharmacology of the inhibitory glycine receptor: agonist and antagonist actions of amino acids and piperidine carboxylic acid compounds.
    V Schmieden and H Betz
    Molecular Pharmacology November 1995, 48 (5) 919-927;
  • You have access
    Inhibition of succinate:ubiquinone reductase and decrease of ubiquinol in nephrotoxic cysteine S-conjugate-induced oxidative cell injury.
    B van de Water, J P Zoeteweij, H J de Bont and J F Nagelkerke
    Molecular Pharmacology November 1995, 48 (5) 928-937;
  • You have access
    Zinc ions antagonize the inhibitory effect of aurothiomalate on glucocorticoid receptor function at physiological concentrations.
    H Tanaka, Y Makino, K Dahlman-Wright, J A Gustafsson, K Okamoto, I Makino and K ] Wright KD [corrected to Dahlman-Wright
    Molecular Pharmacology November 1995, 48 (5) 938-945;
  • You have access
    Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.
    T H Johansen, A Chaudhary and T A Verdoorn
    Molecular Pharmacology November 1995, 48 (5) 946-955;
  • You have access
    Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells.
    V A Boundy, M A Pacheco, W Guan and P B Molinoff
    Molecular Pharmacology November 1995, 48 (5) 956-964;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 48, Issue 5
1 Nov 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics